Cipla, which has recently acquired Brazil's Duomed Produtos Farmaceuticos Ltd and Uganda-based Quality Chemicals Ltd (QCL), is now looking to grow organically. The pharma major's MD and CEO Subhanu Saxena says the company is aiming at achieving a growth of 70-80 percent growth without making any major acquisitions in the near future.Watch video for more.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
